Skip to product information
1 of 1

WhatsApp USA: +1 6032769350 | WhatsApp HK: +852 63697831

Global Healthcare Medical

EDAN SE-2012 Holter Recorder

EDAN SE-2012 Holter Recorder

Regular price $3,199.00
Regular price Sale price $3,199.00
Sale Sold out
Free worldwide shipping. Shipping included in the price.

The EDAN SE-2012 is the 12-channel flagship recorder in EDAN‘s SE-2003/SE-2012 Holter System, designed for extended ambulatory ECG recording in patients who need full 12-lead coverage without the constraints of a bedside monitor. It pairs a recorder weighing approximately 50 g (without battery) with EDAN’s Holter Analysis Software, forming a complete acquisition-and-analysis workflow for clinics, cardiology practices, and hospital ECG departments.

The SE-2012 is FDA-cleared under 510(k) K151787 (January 27, 2016) as part of the SE-2003/SE-2012 Holter System. Its cleared intended use covers recording, analysis, display, editing, and report generation of ambulatory ECG, for adult and pediatric patients, including infants weighing less than 10 kg, with analysis results offered to physicians on an advisory basis only. The cleared indications cover evaluation of symptoms suggesting arrhythmia or myocardial ischemia, ST segment changes, drug response in patients taking anti-arrhythmic medications, and patients with pacemakers.

Where the SE-2012 differs from the 3-channel SE-2003 is its dual recording architecture: it can capture full-disclosure 12-lead ECG for 24–48 hours using a 10-electrode cable, or switch to 3-channel ECG for 24–96 hours using 7- or 5-electrode cables. This allows one recorder to serve both comprehensive 12-lead studies and longer-duration 3-channel rhythm surveillance, depending on the clinical question. The recorder is IP27-rated for water and dust protection, supports real-time waveform display on an OLED screen, and includes an event marker button for flagging symptomatic episodes.

The SE-2012 is built for facilities that need a single Holter platform capable of both 12-lead diagnostic depth and extended 3-channel recording, backed by a mature analysis software suite covering arrhythmia, ST segment, atrial fibrillation, HRV, HRT, and pacemaker detection.

Key Features & Benefits

Dual-Mode Recording: 12-Lead Depth or Extended 3-Channel Duration

The SE-2012 supports three lead configurations: 10-electrode standard 12-lead mode, 7-electrode 3-channel mode, and 5-electrode 3-channel mode. In 12-lead mode, it records full-disclosure 12-lead ECG for 24–48 hours; in 3-channel mode, recording can extend to 24–96 hours. This dual capability means the same recorder can be deployed for detailed 12-lead analysis or for longer rhythm surveillance without purchasing a second device.

IP27 Waterproof and Approximately 50 g Lightweight Design

The IP27 rating provides water and dust protection, supporting easy cleaning and reducing the risk of accidental water damage during daily wear. At approximately 50 g (without battery) , the recorder is designed for patient comfort during multi-day recordings, minimizing the burden of carrying the device through normal activities.

Real-Time Waveform Display and Patient Event Marker

The recorder includes a 1.46-inch OLED screen with real-time waveform display, allowing setup confirmation and signal-quality checks at the point of application. The event marker button (M) lets patients flag symptomatic episodes or meaningful timestamps—such as exercise onset or sleep—so those periods receive focused attention during review.

Holter Analysis Software with Multi-Parameter Review Tools

The included software supports full-disclosure waveform review, automatic and manual editing, arrhythmia analysis, ST-segment analysis with myocardial ischemia evaluation, atrial fibrillation analysis, HRV analysis, and HRT analysis. Graphical assistive tools—R-R Histogram, Waveform Superposition Heat Map, and Lorenz Plot (Poincaré Plot) —help users locate and select abnormal beats efficiently during long recordings.

Pacemaker Detection Aligned with Cleared Indications

The SE-2012 supports pacemaker pulse detection, aligning with its cleared indication for evaluation of patients with pacemakers. This allows the same platform to serve both general arrhythmia evaluation and pacemaker patient follow-up.

Optional Advanced Analysis Modules

Optional software upgrades extend the analysis toolkit with Vector ECG, Ventricular Late Potentials, T-wave Alternans, and Waterfall Plot functions, allowing departments to tailor the platform to specific clinical or research interests.

Standardized Cable and Accessory Ecosystem

The SE-2012 ships standard with a 12-lead ECG cable and is compatible with 7-electrode and 5-electrode cables in IEC or AHA configurations, supporting facilities that have standardized on a particular electrode format. A carry belt, USB cable, and disposable electrodes are included as standard accessories.

Technical Specifications



Specification Detail
Device Type 12-channel / 3-channel digital Holter recorder with analysis software
Recording Modes 12-lead (10-electrode); 3-channel (7-electrode or 5-electrode)
12-Lead Recording Duration 24–48 hours, full-disclosure, non-compressed
3-Channel Recording Duration 24–96 hours, full-disclosure, non-compressed
Storage Removable SD/microSD flash card (capacity per included card)
Display 1.46-inch OLED with real-time waveform display
Sampling Rate 128–1024 Hz
A/D Conversion 8, 12, 16, 18-bit
Frequency Response 0.05–60 Hz
Input Impedance ≥ 20 MΩ
Power Single AAA battery (alkaline or Li-Fe; Li-Fe supports extended recording per labeling)
Ingress Protection IP27 (water and dust protected)
Weight Approximately 50 g (without battery)
Dimensions Approximately 68 × 53 × 16 mm (per published specifications)
Event Marker Yes, patient-activated event marking
Pacemaker Detection Supported
Software Functions Full disclosure; arrhythmia analysis; ST segment analysis; AFib/AFlut analysis; HRV; HRT; pacemaker analysis; R-R Histogram; Waveform Superposition Heat Map; Lorenz Plot; customizable toolbar
Optional Upgrades Vector ECG; Ventricular Late Potentials; T-wave Alternans; Waterfall Plot
Intended Patient Population Adult and pediatric patients, including infants weighing less than 10 kg
Intended Use Recording, analysis, display, editing, and report generation of ambulatory ECG; analysis results advisory only; use by trained personnel under physician direction (FDA 510(k) K151787)
Regulatory Status FDA 510(k) cleared (SE-2003/SE-2012 Holter System: K151787, January 27, 2016); availability and cleared claims vary by market

Why Choose the EDAN SE-2012?



Clinical or Operational Challenge SE-2012 Solution
Need both 12-lead diagnostic depth and extended rhythm surveillance Dual-mode recording: 12-lead for 24–48 hours, or 3-channel for 24–96 hours
Patients need a comfortable recorder for multi-day wear Approximately 50 g (without battery), IP27 water/dust protection
Need to confirm signal quality at setup and during recording OLED screen with real-time waveform display
Need to flag symptomatic episodes for focused review Patient-activated event marker button
Need a mature analysis platform for arrhythmia, ST, AFib, and HRV Holter Analysis Software with full disclosure, multiple analysis modules, and graphical assistive tools
Need pacemaker evaluation capability Pacemaker detection supported under cleared indications
Need to match existing ECG cable formats 12-lead, 7-electrode, and 5-electrode cables in IEC or AHA configurations
Need to extend analysis for specific clinical interests Optional Vector ECG, Ventricular Late Potentials, T-wave Alternans, and Waterfall Plot upgrades
View full details